QuantifiCare’s LifeViz Infinity Pro Awarded Best Aesthetic Device Monaco / April 1st 2022 Following the successful launch of its premium, new 3D Aesthetic photography system, QuantifiCare was awarded the Best Aesthetic Device for the LifeViz® Infinity Pro at...
The Partnership Will Utilize QuantifiCare’s DermaPix Mobile™ Image Management Application in Combination with FotoFinder’s DermLite handyscope™ device for Smartphones. ATLANTA, GA – June 25th, 2021– QuantifiCare, the leading provider of validated clinical trial...
Year after year, QuantifiCare is continuing to expand its geographic footprint. We are proud to welcome our newest distributor, GM Medical, who will cover the Denmark regions. Headquartered in Copenhagen, GM Medical is a Danish company that markets medical technology...
QuantifiCare’s mobile solution, DermaPix Mobile®, is a timely adjunct for clinical dermatology trials combining Patient, Monitor, CRO and Sponsor access in a compliant, validated, and simple way using an app. The app is fully customizable and scalable depending on...
Monaco, France / November 19th 2019 – In recognition of its dedication to breakthrough innovations in the field of Aesthetic and Anti-aging Medicine, Quantificare was awarded the Best Aesthetic Device for the LifeViz® Micro at the 2019 Monte-Carlo Aesthetics...
QuantifiCare partners with LBO France to accelerate its global expansion. LBO France invests €5m through its new Digital Health 2 venture fund. 3 September 2019 Sophia Antipolis, France – QuantifiCare, a global leader in 3D imaging solutions for...